Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Lukuaika: 3 minuutti(s) Kongressin kohokohdat Insights into the neurobiology of functional movement disorders At a joint MDS-European Section and EAN 2019 workshop session focusing on “Functional... Content action menuShareTestTest 2Test 3
Mental health Lukuaika: 3 minuutti(s) Artikla Aiming for personalized treatment — detecting true-positive subgroups The ultimate goal for personalized medicine is to prescribe the right treatment for the right... Content action menuShareTestTest 2Test 3
Skitsofrenia Lukuaika: 1 minuutti(s)Video Video #2: Patients at the center Content action menuShareTestTest 2Test 3
Skitsofrenia Lukuaika: 1 minuutti(s)Video Video #6: Which patients are best suited for long-acting injectable antipsychotics? Content action menuShareTestTest 2Test 3
Mental health Lukuaika: 3 minuutti(s) Kongressin kohokohdat Brightening mental health for the future The future of mental health globally will be bright if we make it bright, said a renowned expert in... Content action menuShareTestTest 2Test 3
Mental health Lukuaika: 4 minuutti(s) Kongressin kohokohdat The Lancet Psychiatry Commission: A blueprint for protecting physical health in people with mental illness The Lancet Psychiatry Commission: A blueprint for protecting physical health in people with mental... Content action menuShareTestTest 2Test 3
Parkinsonin tauti Lukuaika: 3 minuutti(s) Kongressin kohokohdat EAN 2019: Research highlights in Parkinson’s disease 2019 is a bumper year for research, with over 850 abstracts on movement disorders presented at the... Content action menuShareTestTest 2Test 3
Masennus Lukuaika: 4 minuutti(s) Satelliitti-symposium Patient goals and measuring outcome crucial in MDD Asking people what they most want from depression treatment, treating to target, measurement-based... Content action menuShareTestTest 2Test 3
Skitsofrenia Lukuaika: 5 minuutti(s) Satelliitti-symposium Treatment outcomes in schizophrenia – what matters to patients? Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression... Content action menuShareTestTest 2Test 3
Masennus Lukuaika: 4 minuutti(s) Satelliitti-symposium Emotional blunting: unresolved MDD symptom or effect of treatment? Some evidence suggests that emotional blunting is a side effect of therapy, but other evidence... Content action menuShareTestTest 2Test 3
Lukuaika: 1 minuutti(s)Video How can we better understand the risk of suicide clinically? Content action menuShareTestTest 2Test 3
Parkinsonin tauti Lukuaika: 3 minuutti(s) Kongressin kohokohdat Early detection, treatment and the potential for future prevention is the precursor of a new era in Parkinson’s disease Detecting Parkinson’s disease (PD) early is essential so that therapy may be given as early... Content action menuShareTestTest 2Test 3